{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:14:30Z","timestamp":1776068070151,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T00:00:00Z","timestamp":1348617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T00:00:00Z","timestamp":1348617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Nutr"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/ejcn.2012.120","type":"journal-article","created":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T09:11:51Z","timestamp":1348650711000},"page":"1219-1223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Concomitant use of enteral nutrition therapy is associated with sustained response to infliximab in patients with Crohn\u2019s disease"],"prefix":"10.1038","volume":"66","author":[{"given":"S","family":"Sazuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Yokosuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,26]]},"reference":[{"key":"BFejcn2012120_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ . Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474: 307\u2013317.","journal-title":"Nature"},{"key":"BFejcn2012120_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10208","volume":"474","author":"KJ Maloy","year":"2011","unstructured":"Maloy KJ, Powrie F . Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474: 298\u2013306.","journal-title":"Nature"},{"key":"BFejcn2012120_CR3","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","volume":"140","author":"W Strober","year":"2011","unstructured":"Strober W, Fuss IJ . Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140: 1756\u20131767.","journal-title":"Gastroenterology"},{"key":"BFejcn2012120_CR4","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1053\/j.gastro.2011.02.045","volume":"140","author":"D Burger","year":"2011","unstructured":"Burger D, Travis S . Conventional medical management of inflammatory bowel disease. Gastroenterology 2011; 140: 1827\u20131837. ; e1822.","journal-title":"Gastroenterology"},{"key":"BFejcn2012120_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1365-2036.2011.04598.x","volume":"33","author":"S Danese","year":"2011","unstructured":"Danese S, Colombel JF, Reinisch W, Rutgeerts PJ . Review article: infliximab for Crohn\u2019s disease treatment\u2014shifting therapeutic strategies after 10 years of clinical experience. Aliment Pharmacol Ther 2011; 33: 857\u2013869.","journal-title":"Aliment Pharmacol Ther"},{"key":"BFejcn2012120_CR6","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","volume":"337","author":"SR Targan","year":"1997","unstructured":"Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease. Crohn\u2019s Disease cA2 Study Group. N Engl J Med 1997; 337: 1029\u20131035.","journal-title":"N Engl J Med"},{"key":"BFejcn2012120_CR7","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","volume":"359","author":"SB Hanauer","year":"2002","unstructured":"Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF et al. Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial. Lancet 2002; 359: 1541\u20131549.","journal-title":"Lancet"},{"key":"BFejcn2012120_CR8","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJMoa030815","volume":"350","author":"BE Sands","year":"2004","unstructured":"Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN et al. Infliximab maintenance therapy for fistulizing Crohn\u2019s disease. N Engl J Med 2004; 350: 876\u2013885.","journal-title":"N Engl J Med"},{"key":"BFejcn2012120_CR9","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/ajg.2008.88","volume":"104","author":"JP Gisbert","year":"2009","unstructured":"Gisbert JP, Panes J . Loss of response and requirement of infliximab dose intensification in Crohn\u2019s disease: a review. Am J Gastroenterol 2009; 104: 760\u2013767.","journal-title":"Am J Gastroenterol"},{"key":"BFejcn2012120_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1365-2036.2011.04612.x","volume":"33","author":"S Ben-Horin","year":"2011","unstructured":"Ben-Horin S, Chowers Y . Review article: loss of response to anti-TNF treatments in Crohn\u2019s disease. Aliment Pharmacol Ther 2011; 33: 987\u2013995.","journal-title":"Aliment Pharmacol Ther"},{"key":"BFejcn2012120_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2036.2011.04679.x","volume":"34","author":"S Danese","year":"2011","unstructured":"Danese S, Fiorino G, Reinisch W . Review article: Causative factors and the clinical management of patients with Crohn\u2019s disease who lose response to anti-TNF-alpha therapy. Aliment Pharmacol Ther 2011; 34: 1\u201310.","journal-title":"Aliment Pharmacol Ther"},{"key":"BFejcn2012120_CR12","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","volume":"362","author":"JF Colombel","year":"2010","unstructured":"Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D et al. Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease. N Engl J Med 2010; 362: 1383\u20131395.","journal-title":"N Engl J Med"},{"key":"BFejcn2012120_CR13","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1136\/gut.2006.099978","volume":"56","author":"S Vermeire","year":"2007","unstructured":"Vermeire S, Noman M, Van Assche G, Baert F, D\u2019Haens G, Rutgeerts P . Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn\u2019s disease. Gut 2007; 56: 1226\u20131231.","journal-title":"Gut"},{"key":"BFejcn2012120_CR14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/gut.2008.155812","volume":"58","author":"F Schnitzler","year":"2009","unstructured":"Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G et al. Long-term outcome of treatment with infliximab in 614 patients with Crohn\u2019s disease: results from a single-centre cohort. Gut 2009; 58: 492\u2013500.","journal-title":"Gut"},{"key":"BFejcn2012120_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2036.2010.04523.x","volume":"33","author":"U Kopylov","year":"2011","unstructured":"Kopylov U, Mantzaris GJ, Katsanos KH, Reenaers C, Ellul P, Rahier JF et al. The efficacy of shortening the dosing interval to once every six weeks in Crohn\u2019s patients losing response to maintenance dose of infliximab. Aliment Pharmacol Ther 2011; 33: 349\u2013357.","journal-title":"Aliment Pharmacol Ther"},{"key":"BFejcn2012120_CR16","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1007\/BF02237231","volume":"43","author":"T Yao","year":"2000","unstructured":"Yao T, Matsui T, Hiwatashi N . Crohn\u2019s disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000; 43: S85\u2013S93.","journal-title":"Dis Colon Rectum"},{"key":"BFejcn2012120_CR17","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/j.1440-1746.2006.04317.x","volume":"21","author":"T Tanaka","year":"2006","unstructured":"Tanaka T, Takahama K, Kimura T, Mizuno T, Nagasaka M, Iwata K et al. Effect of concurrent elemental diet on infliximab treatment for Crohn\u2019s disease. J Gastroenterol Hepatol 2006; 21: 1143\u20131149.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFejcn2012120_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1046\/j.1365-2036.2003.01482.x","volume":"17","author":"J Goh","year":"2003","unstructured":"Goh J, O\u2019Morain CA . Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther 2003; 17: 307\u2013320.","journal-title":"Aliment Pharmacol Ther"},{"key":"BFejcn2012120_CR19","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1177\/01486071050290S4S108","volume":"29","author":"AM Griffiths","year":"2005","unstructured":"Griffiths AM . Enteral nutrition in the management of Crohn\u2019s disease. J Parenter Enteral Nutr 2005; 29: S108\u2013S112. discussion S112\u2013107, S184\u2013108.","journal-title":"J Parenter Enteral Nutr"},{"key":"BFejcn2012120_CR20","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/ibd.20271","volume":"13","author":"H Lochs","year":"2007","unstructured":"Lochs H . Enteral nutrition-the new maintenance therapy in Crohn\u2019s disease? Inflamm Bowel Dis 2007; 13: 1581\u20131582.","journal-title":"Inflamm Bowel Dis"},{"key":"BFejcn2012120_CR21","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/gut.32.12.1492","volume":"32","author":"D Rigaud","year":"1991","unstructured":"Rigaud D, Cosnes J, Le Quintrec Y, Rene E, Gendre JP, Mignon M . Controlled trial comparing two types of enteral nutrition in treatment of active Crohn\u2019s disease: elemental versus polymeric diet. Gut 1991; 32: 1492\u20131497.","journal-title":"Gut"},{"key":"BFejcn2012120_CR22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1572-0241.2000.01527.x","volume":"95","author":"S Verma","year":"2000","unstructured":"Verma S, Brown S, Kirkwood B, Giaffer MH . Polymeric versus elemental diet as primary treatment in active Crohn\u2019s disease: a randomized, double-blind trial. Am J Gastroenterol 2000; 95: 735\u2013739.","journal-title":"Am J Gastroenterol"},{"key":"BFejcn2012120_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/gut.41.4.487","volume":"41","author":"CK Ameho","year":"1997","unstructured":"Ameho CK, Adjei AA, Harrison EK, Takeshita K, Morioka T, Arakaki Y et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut 1997; 41: 487\u2013493.","journal-title":"Gut"},{"key":"BFejcn2012120_CR24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0016-5085(03)01067-9","volume":"125","author":"I Tsune","year":"2003","unstructured":"Tsune I, Ikejima K, Hirose M, Yoshikawa M, Enomoto N, Takei Y et al. Dietary glycine prevents chemical-induced experimental colitis in the rat. Gastroenterology 2003; 125: 775\u2013785.","journal-title":"Gastroenterology"},{"key":"BFejcn2012120_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1053\/j.gastro.2008.09.062","volume":"136","author":"A Andou","year":"2009","unstructured":"Andou A, Hisamatsu T, Okamoto S, Chinen H, Kamada N, Kobayashi T et al. Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages. Gastroenterology 2009; 136: 564\u2013574. ; e562.","journal-title":"Gastroenterology"},{"key":"BFejcn2012120_CR26","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/gut.2004.062554","volume":"55","author":"T Johnson","year":"2006","unstructured":"Johnson T, Macdonald S, Hill SM, Thomas A, Murphy MS . Treatment of active Crohn\u2019s disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut 2006; 55: 356\u2013361.","journal-title":"Gut"},{"key":"BFejcn2012120_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/00054725-200002000-00016","volume":"6","author":"BI Korelitz","year":"2000","unstructured":"Korelitz BI . The role of liquid diet in the management of small bowel Crohn\u2019s disease. Inflamm Bowel Dis 2000; 6: 66\u201367. ; discussion 68\u201369.","journal-title":"Inflamm Bowel Dis"},{"key":"BFejcn2012120_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/BF02776982","volume":"28","author":"H Hirakawa","year":"1993","unstructured":"Hirakawa H, Fukuda Y, Tanida N, Hosomi M, Shimoyama T . Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn\u2019s disease. Gastroenterol Jpn 1993; 28: 379\u2013384.","journal-title":"Gastroenterol Jpn"},{"issue":"Suppl 8","key":"BFejcn2012120_CR29","first-page":"83","volume":"30","author":"Y Fukuda","year":"1995","unstructured":"Fukuda Y, Kosaka T, Okui M, Hirakawa H, Shimoyama T . Efficacy of nutritional therapy for active Crohn\u2019s disease. J Gastroenterol 1995; 30 (Suppl 8), 83\u201387.","journal-title":"J Gastroenterol"},{"key":"BFejcn2012120_CR30","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1365-2036.2006.03120.x","volume":"24","author":"S Takagi","year":"2006","unstructured":"Takagi S, Utsunomiya K, Kuriyama S, Yokoyama H, Takahashi S, Iwabuchi M et al. Effectiveness of an \u2018half elemental diet\u2019 as maintenance therapy for Crohn\u2019s disease: a randomized-controlled trial. Aliment Pharmacol Ther 2006; 24: 1333\u20131340.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["European Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ejcn2012120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ejcn2012120","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ejcn2012120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T13:07:41Z","timestamp":1648213661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejcn2012120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,26]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["BFejcn2012120"],"URL":"https:\/\/doi.org\/10.1038\/ejcn.2012.120","relation":{},"ISSN":["0954-3007","1476-5640"],"issn-type":[{"value":"0954-3007","type":"print"},{"value":"1476-5640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,26]]},"assertion":[{"value":"24 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}